AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN SPAIN: A COST-EFFECTIVENESS ANALYSIS
VALUE IN HEALTH（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined